Point-Of-Care Testing Market Share, Size, Forecast and Trends by 2021 | Research Cosmos

25/gen/2018 10:27:54 Research Cosmos Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global point-of-care testing market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.


Based on geography, the Global Point-Of-Care Testing Market is segmented into 5 geographical regions, such as,


North America,

South America,




Rest of the World


Explore More Information about report @ https://www.researchcosmos.com/reports/point-of-care-testing-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/600304112


Global point-of-care testing market competition by top players including –


F. Hoffmann-La Roche Ltd is going to dominate the Point-Of-Care Testing market following with Siemens AG and Abbott Laboratories, Inc., along with others such as

Beckman Coulter, Inc.,

Becton, Dickinson and Company,

Johnson & Johnson, Alere Inc.,

Instrumentation Laboratory,

PTS Diagnostics, Abaxis, Inc.,

Medtronic, Accriva Diagnostics,

OPTI Medical, Sienco, Inc.,

Alpha Scientific,

AccuBioTech Co., Ltd.,

ACON Laboratories, Inc.,

Acrongenomics, Inc.,

bioMérieux SA,

Biomerica, Inc.,

Atlas Genetics Ltd.,

Alfa Scientific Designs, Inc.,

Bio-Rad Laboratories, Inc.,

Medica Corporation,

Nova Biomedica.


Request free sample @ https://www.researchcosmos.com/request/600304112


The global point-of-care testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.


On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.


Inquire before buying @ https://www.researchcosmos.com/inquire/600304112


Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.


Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.


Check for discount @ https://www.researchcosmos.com/discount/600304112


On the basis of distribution channel, the market is segmented into direct tenders and retail.


On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal). Also, clinic is segmented into physicians’ clinic and diagnostic clinic.


About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.



Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com



blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl